DrugMay 3, 2023
Tadalafil Tablets, USP 20 mg recall — FDA D-0553-2023
CGMP Deviations
Class IIFDA: OngoingNorthwind Pharmaceuticals LLC
Latest records
Latest recalls — page 284
The newest recall records with useful source details are listed here.
DrugMay 3, 2023
Methapharm Pantoprazole sodium for Injection 40 mg*/vial, Single-dose Vial recall — FDA D-0540-2023
CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.
Class IIFDA: CompletedMethapharm Inc.
VehicleApr 28, 2023
Explorer Police Interceptor Utility display function recall — NHTSA campaign 23V305000
Ford Motor Company (Ford) is recalling certain 2020-2022 Explorer Police Interceptor Utility vehicles equipped with a 12.1-inch Integrated Computer Screen (ICS). When the Display On/Off…
display functionFord Motor Company
VehicleApr 27, 2023
Jeep Wrangler Plug-In Hybrid Electric traction battery recall — NHTSA campaign 23V303000
Chrysler (FCA US, LLC) is recalling certain 2022-2023 Jeep Wrangler Plug-In Hybrid Electric vehicles (PHEV). The high voltage (HV) battery pack assembly was built with incorrect fasteners…
traction batteryChrysler (FCA US, LLC)
VehicleApr 27, 2023
Ram ProMaster park pawl recall — NHTSA campaign 23V301000
Chrysler (FCA US, LLC) is recalling certain 2019-2021 Ram ProMaster vehicles equipped with a 62TE transmission. The park pawl may not fully engage the park gear due to debris inside the…
park pawlChrysler (FCA US, LLC)
DrugApr 26, 2023
Amerisource Health Services Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg recall — FDA D-0536-2023
Failed Dissolution Specifications: Out of specification dissolution results above specified values.
Class IIFDA: TerminatedAmerisource Health Services LLC
DrugApr 26, 2023
Pharma Nobis Fast Acting Earwax Removal System (carbamide peroxide), 6.5%, 0.5 FL OZ (15 mL) recall — FDA D-0537-2023
CGMP Deviations: active ingredient may be subpotent before the labeled expiry due to degradation.
Class IIFDA: OngoingPharma Nobis LLC
VehicleApr 26, 2023
Kia instrument cluster/panel recall — NHTSA campaign 23V298000
Kia America, Inc. (Kia) is recalling certain 2023 Sportage, Sportage Hybrid, Sportage Plug-in Hybrid, Niro Hybrid, Niro Plug-in Hybrid, Soul, and Telluride vehicles equipped with a digital…
instrument cluster/panelKia America, Inc.
VehicleApr 25, 2023
Impreza switch recall — NHTSA campaign 23V292000
Subaru of America, Inc. (Subaru) is recalling certain 2023 Impreza vehicles. The brake light switch may be improperly adjusted and illuminate the brake lights without application of the…
switchSubaru of America, Inc.
VehicleApr 20, 2023
Ford lugs/nuts/bolts/studs recall — NHTSA campaign 23V283000
Ford Motor Company (Ford) is recalling certain 2023 Bronco and Ranger vehicles. The lug nuts on the driver's side wheels may have been improperly tightened.
lugs/nuts/bolts/studsFord Motor Company
DrugApr 19, 2023
Norepinephrine Bitartrate Injection, USP, 4 mg/4 mL* (1 mg/mL), 4 mL Single-dose Fliptop recall — FDA D-0529-2023
Failed Impurities/Degradation Specifications: Above the specification limits yielded for related substance norepinephrine sulfonic acid impurity during routine product monitoring.
Class IIIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugApr 19, 2023
MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle recall — FDA D-0532-2023
Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.
Class IIIFDA: OngoingPfizer Inc.
DrugApr 19, 2023
Pine Pharmaceuticals Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free recall — FDA D-0531-2023
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
Class IIIFDA: TerminatedPine Pharmaceuticals, LLC
DrugApr 19, 2023
Epinephrine Professional EMS, Epinephrine Convenience Kit, Epinephrine 1 mg/mL recall — FDA D-0535-2023
Labeling; Incorrect NDC number on outer carton of product.
Class IIIFDA: OngoingFocus Health Group Inc.
VehicleApr 18, 2023
Mazda North American Operations control unit/module recall — NHTSA campaign 23V275000
Mazda North American Operations (Mazda) is recalling certain 2022-2023 CX-30 and 2023 CX-50 vehicles. The anti-lock brake system (ABS) Hydraulic Control Unit (HCU) may be damaged, which can…
control unit/moduleMazda North American Operations
VehicleApr 17, 2023
Nissan bead recall — NHTSA campaign 23V273000
Nissan North America, Inc. (Nissan) is recalling certain 2023 Titan and Frontier vehicles. The tires may have a tear in the inner bead which can cause a rapid loss of tire pressure.
beadNissan North America, Inc.
VehicleApr 13, 2023
Nissan critical fasteners recall — NHTSA campaign 23V268000
Nissan North America, Inc. (Nissan) is recalling certain 2023 Rogue, Pathfinder, and Infiniti QX60 vehicles. The driver's powered seat may not be fully secured to the seat frame, causing…
critical fastenersNissan North America, Inc.
VehicleApr 13, 2023
Ram 1500 control module (tcm/pcm/tecm) recall — NHTSA campaign 23V265000
Chrysler (FCA US, LLC) is recalling certain 2021 Ram 1500 vehicles equipped with 5.7L eTorque engines. The powertrain control module software may cause an incorrect fuel mixture condition…
control module (tcm/pcm/tecm)Chrysler (FCA US, LLC)
VehicleApr 13, 2023
Ram 1500 side impact recall — NHTSA campaign 23V264000
Chrysler (FCA US, LLC) is recalling certain 2022 Ram 1500 vehicles. The B-pillar impact sensors may be missing, which can result in delayed air bag deployment or non-deployment.
side impactChrysler (FCA US, LLC)
VehicleApr 13, 2023
Chrysler fuel pump recall — NHTSA campaign 23V263000
Chrysler (FCA US, LLC) is recalling certain 2021-2023 Jeep Wrangler, Gladiator, and 2022-2023 Ram 1500 vehicles equipped with a 3.0L diesel engine. The high pressure fuel pump (HPFP) may…
fuel pumpChrysler (FCA US, LLC)
DrugApr 12, 2023
Testosterone Cypionate Injection, USP, CIII, 200 mg/mL recall — FDA D-0489-2023
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Class IIFDA: TerminatedAzurity Pharmaceuticals, Inc.
DrugApr 12, 2023
Preferred Pharmaceuticals Alprazolam Tab, USP 0.5mg, (CIV) recall — FDA D-0505-2023
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Class IIFDA: TerminatedPreferred Pharmaceuticals, Inc.
DrugApr 12, 2023
Preferred Pharmaceuticals Simvastatin Tablets, USP, 40 mg, Packaged as: a) 90-count bottle recall — FDA D-0525-2023
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class IIFDA: OngoingPreferred Pharmaceuticals, Inc.
DrugApr 12, 2023
Preferred Pharmaceuticals Simvastatin Tablets, USP, 20 mg, Packaged as: a) 90-count bottle recall — FDA D-0524-2023
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class IIFDA: OngoingPreferred Pharmaceuticals, Inc.
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categories